TrialInternational journal of clinical oncology2013

Pancreatic carcinoma-specific immunotherapy using synthesised alpha-galactosyl epitope-activated immune responders: findings from a pilot study.

Ying Qiu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.